ZILLOW GROUP INC - C (Z) Stock Fundamental Analysis

USA Nasdaq NASDAQ:Z • US98954M2008

54.97 USD
+0.96 (+1.78%)
At close: Feb 6, 2026
54.95 USD
-0.02 (-0.04%)
After Hours: 2/6/2026, 8:12:32 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to Z. Z was compared to 62 industry peers in the Real Estate Management & Development industry. Z has a great financial health rating, but its profitability evaluates not so good. Z is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • Z had positive earnings in the past year.
  • Z had a positive operating cash flow in the past year.
  • Z had negative earnings in each of the past 5 years.
  • Of the past 5 years Z 4 years had a positive operating cash flow.
Z Yearly Net Income VS EBIT VS OCF VS FCFZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

  • Z has a Return On Assets of -0.56%. This is comparable to the rest of the industry: Z outperforms 48.39% of its industry peers.
  • The Return On Equity of Z (-0.64%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.56%
ROE -0.64%
ROIC N/A
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
Z Yearly ROA, ROE, ROICZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

  • With an excellent Gross Margin value of 74.87%, Z belongs to the best of the industry, outperforming 88.71% of the companies in the same industry.
  • Z's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for Z so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
Z Yearly Profit, Operating, Gross MarginsZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

  • Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Z has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for Z has been increased compared to 5 years ago.
  • Z has a better debt/assets ratio than last year.
Z Yearly Shares OutstandingZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
Z Yearly Total Debt VS Total AssetsZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • Z has an Altman-Z score of 11.36. This indicates that Z is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 11.36, Z belongs to the best of the industry, outperforming 90.32% of the companies in the same industry.
  • The Debt to FCF ratio of Z is 1.83, which is an excellent value as it means it would take Z, only 1.83 years of fcf income to pay off all of its debts.
  • Z's Debt to FCF ratio of 1.83 is amongst the best of the industry. Z outperforms 85.48% of its industry peers.
  • Z has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • Z has a Debt to Equity ratio of 0.05. This is in the better half of the industry: Z outperforms 77.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.83
Altman-Z 11.36
ROIC/WACCN/A
WACC8.36%
Z Yearly LT Debt VS Equity VS FCFZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

  • Z has a Current Ratio of 3.63. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 3.63, Z is doing good in the industry, outperforming 79.03% of the companies in the same industry.
  • A Quick Ratio of 3.63 indicates that Z has no problem at all paying its short term obligations.
  • Z has a better Quick ratio (3.63) than 82.26% of its industry peers.
Industry RankSector Rank
Current Ratio 3.63
Quick Ratio 3.63
Z Yearly Current Assets VS Current LiabilitesZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • Z shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.92%, which is quite good.
  • Looking at the last year, Z shows a quite strong growth in Revenue. The Revenue has grown by 15.17% in the last year.
  • Measured over the past years, Z shows a decrease in Revenue. The Revenue has been decreasing by -4.00% on average per year.
EPS 1Y (TTM)16.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
Revenue 1Y (TTM)15.17%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%16.35%

3.2 Future

  • Based on estimates for the next years, Z will show a very strong growth in Earnings Per Share. The EPS will grow by 30.58% on average per year.
  • Based on estimates for the next years, Z will show a quite strong growth in Revenue. The Revenue will grow by 14.16% on average per year.
EPS Next Y23.19%
EPS Next 2Y28.27%
EPS Next 3Y30.47%
EPS Next 5Y30.58%
Revenue Next Year15.85%
Revenue Next 2Y15.13%
Revenue Next 3Y14.47%
Revenue Next 5Y14.16%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
Z Yearly Revenue VS EstimatesZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
Z Yearly EPS VS EstimatesZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4

4

4. Valuation

4.1 Price/Earnings Ratio

  • Z is valuated quite expensively with a Price/Earnings ratio of 36.16.
  • Based on the Price/Earnings ratio, Z is valued a bit cheaper than the industry average as 69.35% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of Z to the average of the S&P500 Index (27.92), we can say Z is valued slightly more expensively.
  • Z is valuated rather expensively with a Price/Forward Earnings ratio of 24.39.
  • Based on the Price/Forward Earnings ratio, Z is valued a bit cheaper than the industry average as 79.03% of the companies are valued more expensively.
  • Z's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.78.
Industry RankSector Rank
PE 36.16
Fwd PE 24.39
Z Price Earnings VS Forward Price EarningsZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of Z is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, Z is valued a bit cheaper than the industry average as 62.90% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 89.3
EV/EBITDA 64.56
Z Per share dataZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • Z's earnings are expected to grow with 30.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.56
PEG (5Y)N/A
EPS Next 2Y28.27%
EPS Next 3Y30.47%

0

5. Dividend

5.1 Amount

  • No dividends for Z!.
Industry RankSector Rank
Dividend Yield 0%

ZILLOW GROUP INC - C

NASDAQ:Z (2/6/2026, 8:12:32 PM)

After market: 54.95 -0.02 (-0.04%)

54.97

+0.96 (+1.78%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-30
Earnings (Next)02-10
Inst Owners99.3%
Inst Owner Change0.99%
Ins Owners6.41%
Ins Owner Change-5.9%
Market Cap13.31B
Revenue(TTM)2.48B
Net Income(TTM)-32.00M
Analysts74.67
Price Target88.28 (60.6%)
Short Float %5.69%
Short Ratio3.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.54%
Min EPS beat(2)-7.26%
Max EPS beat(2)0.18%
EPS beat(4)2
Avg EPS beat(4)-1.47%
Min EPS beat(4)-7.26%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)15.44%
EPS beat(12)10
Avg EPS beat(12)56.38%
EPS beat(16)14
Avg EPS beat(16)88.61%
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.18%
Max Revenue beat(2)-0.78%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.18%
Max Revenue beat(4)-0.3%
Revenue beat(8)4
Avg Revenue beat(8)1.15%
Revenue beat(12)8
Avg Revenue beat(12)2.22%
Revenue beat(16)10
Avg Revenue beat(16)-4.7%
PT rev (1m)-0.52%
PT rev (3m)-2.64%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)3.23%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)1.37%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE 36.16
Fwd PE 24.39
P/S 5.36
P/FCF 89.3
P/OCF 31.83
P/B 2.67
P/tB 7.02
EV/EBITDA 64.56
EPS(TTM)1.52
EY2.77%
EPS(NY)2.25
Fwd EY4.1%
FCF(TTM)0.62
FCFY1.12%
OCF(TTM)1.73
OCFY3.14%
SpS10.26
BVpS20.62
TBVpS7.83
PEG (NY)1.56
PEG (5Y)N/A
Graham Number26.56
Profitability
Industry RankSector Rank
ROA -0.56%
ROE -0.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.87%
FCFM 6%
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.83
Debt/EBITDA 1.57
Cap/Depr 102.28%
Cap/Sales 10.83%
Interest Coverage N/A
Cash Conversion 241.62%
Profit Quality N/A
Current Ratio 3.63
Quick Ratio 3.63
Altman-Z 11.36
F-Score7
WACC8.36%
ROIC/WACCN/A
Cap/Depr(3y)73.5%
Cap/Depr(5y)73.95%
Cap/Sales(3y)7.76%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
EPS Next Y23.19%
EPS Next 2Y28.27%
EPS Next 3Y30.47%
EPS Next 5Y30.58%
Revenue 1Y (TTM)15.17%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%16.35%
Revenue Next Year15.85%
Revenue Next 2Y15.13%
Revenue Next 3Y14.47%
Revenue Next 5Y14.16%
EBIT growth 1Y57.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year433.79%
EBIT Next 3Y93.51%
EBIT Next 5Y58.6%
FCF growth 1Y-21.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.75%
OCF growth 3YN/A
OCF growth 5YN/A

ZILLOW GROUP INC - C / Z FAQ

What is the ChartMill fundamental rating of ZILLOW GROUP INC - C (Z) stock?

ChartMill assigns a fundamental rating of 5 / 10 to Z.


What is the valuation status of ZILLOW GROUP INC - C (Z) stock?

ChartMill assigns a valuation rating of 4 / 10 to ZILLOW GROUP INC - C (Z). This can be considered as Fairly Valued.


What is the profitability of Z stock?

ZILLOW GROUP INC - C (Z) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for Z stock?

The Price/Earnings (PE) ratio for ZILLOW GROUP INC - C (Z) is 36.16 and the Price/Book (PB) ratio is 2.67.


What is the financial health of ZILLOW GROUP INC - C (Z) stock?

The financial health rating of ZILLOW GROUP INC - C (Z) is 8 / 10.